Abstract
ABSTRACTOculocutaneous albinism type 2 (OCA2) is the second most frequent form of albinism and represents about 30% of OCA worldwide. As with all types of OCA, patients present with hypopigmentation of hair and skin as well as severe visual abnormalities. We focused on a subgroup of 29 patients for whom genetic diagnosis was pending because at least one of their identified variants in or around exon 10 ofOCA2is of uncertain significance (VUS). By minigene assay, we investigated the effect of these VUS on exon 10 skipping and showed that not only intronic but also some synonymous variants can result in enhanced exon skipping. We further found that excessive skipping of exon 10 could be detected directly on blood samples of patients and of their one parent with the causal variant, avoiding invasive skin biopsies. Moreover, we show that variants which result in lack of detectableOCA2mRNA can be identified from blood samples as well, as shown for the most commonOCA2pathogenic missense variant c.1327G>A/p.(Val443Ile). In conclusion, blood cell RNA analysis allows testing the potential effect of anyOCA2VUS on transcription products. This should help to elucidate yet unsolved OCA2 patients and improve genetic counseling.SIGNIFICANCEOur study allows us to reconsider variants of unknown significance ofOCA2as pathogenic as they induce exon 10 skipping. We show that mis-splicing as well as other types of transcripts imbalance can be detected directly from blood cell samples, avoiding invasive biopsies. We recommend systematic collection of a blood RNA sample from patients with inconclusive genetic diagnosis and suspected OCA2 (e.g., only one pathogenic variant inOCA2; 1 VUS; 2 VUS intrans).
Publisher
Cold Spring Harbor Laboratory